298 related articles for article (PubMed ID: 6223940)
1. Platelets have more than one binding site for von Willebrand factor.
Ruggeri ZM; De Marco L; Gatti L; Bader R; Montgomery RR
J Clin Invest; 1983 Jul; 72(1):1-12. PubMed ID: 6223940
[TBL] [Abstract][Full Text] [Related]
2. Interaction of von Willebrand factor with human platelets in the plasma milieu.
Schullek J; Jordan J; Montgomery RR
J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of von Willebrand factor-platelet interaction by fibrinogen.
Piétu G; Cherel G; Marguerie G; Meyer D
Nature; 1984 Apr 12-18; 308(5960):648-9. PubMed ID: 6324004
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
6. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor has more than one binding site for platelets.
Nokes TJ; Mahmoud NA; Savidge GF; Goodall AH; Meyer D; Edgington TS; Hardisty RM
Thromb Res; 1984 Jun; 34(5):361-6. PubMed ID: 6610952
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
Parker RI; Gralnick HR
Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
[TBL] [Abstract][Full Text] [Related]
10. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
11. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
Timmons S; Kloczewiak M; Hawiger J
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
[TBL] [Abstract][Full Text] [Related]
12. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor bound to glycoprotein Ib is cleared from the platelet surface after platelet activation by thrombin.
Hourdillé P; Gralnick HR; Heilmann E; Derlon A; Ferrer AM; Vezon G; Nurden AT
Blood; 1992 Apr; 79(8):2011-21. PubMed ID: 1562727
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin.
Gralnick HR; Williams SB; Coller BS
Blood; 1984 Oct; 64(4):797-800. PubMed ID: 6236859
[TBL] [Abstract][Full Text] [Related]
16. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil cathepsin G modulates the platelet surface expression of the glycoprotein (GP) Ib-IX complex by proteolysis of the von Willebrand factor binding site on GPIb alpha and by a cytoskeletal-mediated redistribution of the remainder of the complex.
LaRosa CA; Rohrer MJ; Benoit SE; Barnard MR; Michelson AD
Blood; 1994 Jul; 84(1):158-68. PubMed ID: 7517206
[TBL] [Abstract][Full Text] [Related]
18. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
[TBL] [Abstract][Full Text] [Related]
19. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
De Marco L; Girolami A; Russell S; Ruggeri ZM
J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
[TBL] [Abstract][Full Text] [Related]
20. Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor.
Parker RI; Gralnick HR
Blood; 1986 Sep; 68(3):732-6. PubMed ID: 3017478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
